In mice, the impaired expression of E-cadherin was found to promote hepatocellular carcinogenesis [48], and the dysregulation of E-cadherin was also identified in a number of transgenic mouse models of liver cancer [49]. This evidence concerns the gene CDH1 and liver cancer.